Quarter Financials
Bio-Rad Laboratories, Inc. (BIO)
$478.96
+3.05 (+0.64%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | -164 | -927 | -3,370 | -1,574 | 3,928 | 914 | 977 | 839 |
|---|
| Dividend Paid | -30 | -42 | -20,680 | - | - | - | - | - |
|---|
| Retained Earnings | 9,046 | 9,210 | 10,138 | 13,507 | 15,081 | 11,159 | 10,245 | 9,268 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | -38 | -43 | -28,899 | -43 | -35 | -23 | -20 | -39 |
|---|
| Net PPE | 633 | 656 | 684 | 696 | 681 | 672 | 679 | 694 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | -160 | -75 | -180 | -205 | -845 | -961 | -1,012 | -970 |
|---|
| Intangible and Goodwill | 292 | 292 | 292 | 292 | 347 | 346 | 347 | 400 |
|---|